Acorda Therapeutics, Inc.

Form 483

Pearl River, New York, United StatesFEI 3002457563Issued February 26, 2009

View FDA's Record for This Firm

Source: FDA record for this establishment. FDA publishes inspections or enforcement actions for this establishment, listed further down this page, but we have not matched this particular Form 483 to a document or an inspection date FDA has released. It stays out of the default view for that reason. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3002457563.

Observations5

Issue DateFebruary 26, 2009

StatusNo Warning Letter

Related Inspections10

Establishment Details

Firm: Acorda Therapeutics, Inc.
Location: Pearl River, New York, United States
FEI Number: 3002457563
Product Type: Drugs
Issue Date: February 26, 2009
Country: United States

Inspection History, 2011 to 2020

NAI4

VAI5

OAI1

NAI means No Action Indicated. VAI means Voluntary Action Indicated. OAI means Official Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Acorda Therapeutics, Inc. FDA Form 483, Pearl River, New York, February 26, 2009